Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial by researchers from the University of Pennsylvania Perelman School of Medicine. Hemophilia is a genetic disorder that limits the blood’s […]
The post Single-Dose Gene Therapy is Potentially Life-Changing for Adults with Hemophilia appeared first on Good News Network.
